Pharmaceutically active tetrahydropyrrolo(1,2-b)isothiazole 1,1-dioxides

Details for Australian Patent Application No. 2006298658 (hide)

Owner Novartis AG

Inventors Baumann, Karl

Agent Davies Collison Cave

Pub. Number AU-A-2006298658

PCT Pub. Number WO2007/039616

Priority 0520378.1 06.10.05 GB

Filing date 4 October 2006

Wipo publication date 12 April 2007

International Classifications

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039616 Priority application(s): WO2007/039616

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006298674-Novel selection system

2006298645-Pigment preparation